Stay updated on Amivantamab in Esophagogastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Amivantamab in Esophagogastric Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a website transition and links to updates, stating that federal agencies are using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T13:16:18.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error, and the displayed site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:31:48.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-11T14:11:09.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study page shows a 403 Forbidden error, replacing the expected content with an access-denied notice and preventing viewing the record.
    Difference
    17%
    Check dated 2026-09-20T19:47:49.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.6.5 to v3.6.6, indicating a minor page maintenance update.
    Difference
    0.1%
    Check dated 2026-08-30T21:38:26.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, replacing the previous v3.6.4 revision. This appears to be a small internal update to the page template or rendering, not a change to study content.
    Difference
    0.1%
    Check dated 2026-08-09T09:18:14.000Z thumbnail image

Stay in the know with updates to Amivantamab in Esophagogastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Amivantamab in Esophagogastric Cancer Clinical Trial page.